What does N1303K mutation do?

What does N1303K mutation do?

Conclusion: N1303K has a severe gating defect, reduced ATP-dependence and aberrant response to ATP analogs. These results suggest a defective function of the NBDs in N1303K-CFTR.

What class of mutation is Delta F508?

That is, ΔF508 is a class 2 mutation in the sweat gland but a class 3 mutation in the airway and gut, so a therapy effective in one tissue might not apply to another. Disease of the airway is the major cause of mortality in CF, so understanding the effect of ΔF508 on the respiratory epithelium is of major importance.

What is G551D mutation?

The G551D mutation is the most prevalent gating mutation. It is caused by substitution of the amino acid glycine by aspartate at position 551 in the nucleotide binding domain-1 of the CFTR gene.

What is N1303K?

The N1303K mutation was identified in the second nucleotide binding fold of the cystic fibrosis (CF) gene last year. We have gathered data from laboratories throughout Europe and the United States of America in order to estimate its frequency and to attempt to characterise the clinical manifestations of this mutation.

Does cystic fibrosis lower life expectancy?

Cystic fibrosis tends to get worse over time and can be fatal if it leads to a serious infection or the lungs stop working properly. But people with cystic fibrosis are now living for longer because of advancements in treatment. Currently, about half of people with cystic fibrosis will live past the age of 40.

What causes delta F508 mutation?

The most common mutation in the gene associated with cystic fibrosis (CF) causes deletion of phenylalanine at residue 508 (delta F508) of the gene product called CFTR. This mutation results in the synthesis of a variant CFTR protein that is defective in its ability to traffic to the plasma membrane.

How common is the G551D mutation?

G551D is the third overall most common CF mutation with a worldwide frequency of ∼3% (www.genet.sickkids.on.ca/cftr). This mutation is associated with a severe phenotype characterized by pulmonary dysfunction and pancreatic insufficiency (Cutting et al., 1990; Kerem et al., 1990).

What is W1282X?

W1282X is a common nonsense mutation among cystic fibrosis patients that results in the production of a truncated Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channel.